Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
Introduction Methotrexate (MTX) causes hepatotoxicity by producing oxidative stress. Benfotiamine and irisin have protective effects against oxidative stress. The aim of this study was to investigate the changes in irisin activity in the liver as a result of toxicity produced by MTX and the protecti...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5da203d1c88d4527ad0775cdb99de6c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5da203d1c88d4527ad0775cdb99de6c9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5da203d1c88d4527ad0775cdb99de6c92021-12-02T18:39:22ZProtective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats1734-19221896-915110.5114/aoms.2018.80002https://doaj.org/article/5da203d1c88d4527ad0775cdb99de6c92019-12-01T00:00:00Zhttps://www.archivesofmedicalscience.com/Protective-effects-of-benfotiamine-on-irisin-activity-in-methotrexate-induced-liver,99247,0,2.htmlhttps://doaj.org/toc/1734-1922https://doaj.org/toc/1896-9151Introduction Methotrexate (MTX) causes hepatotoxicity by producing oxidative stress. Benfotiamine and irisin have protective effects against oxidative stress. The aim of this study was to investigate the changes in irisin activity in the liver as a result of toxicity produced by MTX and the protective role of benfotiamine in the hepatotoxicity. Material and methods Rats were divided into 4 groups as follows: control, benfotiamine (50 mg/kg, oral gavage (o.g.), for 14 days), MTX (MTX 20 mg/kg intraperitoneally (i.p.) on day 1), MTX + benfotiamine (MTX 20 mg/kg (i.p.) on day 1, then 50 mg/kg (o.g.) benfotiamine for 14 days). Liver tissue was used to examine histopathological and immunohistochemical changes. Serum was used to look for oxidative stress markers (total antioxidant status (TAS) and total oxidant status (TOS)). Results Administration of MTX caused a significant TOS increase and TAS decrease in the serum as compared to the control group. Immunohistochemically, irisin was significantly increased in immunoreactivity in the MTX group as compared to the control group (p < 0.05). Significant histopathological improvement and decrease in serum TOS levels were observed in the MTX + benfotiamine group compared to the MTX group (p 0.05). Conclusions Our results showed that MTX caused an increase in the activity of irisin after producing toxicity in the liver. In addition, we found that benfotiamine was effective in preventing damage caused by MTX in the liver.Mehmet Ali ErdoganAlper YalcinTermedia Publishing Housearticleirisinliver toxicitybenfotiamineoxidative stressratsMedicineRENArchives of Medical Science, Vol 16, Iss 1, Pp 205-211 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
irisin liver toxicity benfotiamine oxidative stress rats Medicine R |
spellingShingle |
irisin liver toxicity benfotiamine oxidative stress rats Medicine R Mehmet Ali Erdogan Alper Yalcin Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats |
description |
Introduction
Methotrexate (MTX) causes hepatotoxicity by producing oxidative stress. Benfotiamine and irisin have protective effects against oxidative stress. The aim of this study was to investigate the changes in irisin activity in the liver as a result of toxicity produced by MTX and the protective role of benfotiamine in the hepatotoxicity.
Material and methods
Rats were divided into 4 groups as follows: control, benfotiamine (50 mg/kg, oral gavage (o.g.), for 14 days), MTX (MTX 20 mg/kg intraperitoneally (i.p.) on day 1), MTX + benfotiamine (MTX 20 mg/kg (i.p.) on day 1, then 50 mg/kg (o.g.) benfotiamine for 14 days). Liver tissue was used to examine histopathological and immunohistochemical changes. Serum was used to look for oxidative stress markers (total antioxidant status (TAS) and total oxidant status (TOS)).
Results
Administration of MTX caused a significant TOS increase and TAS decrease in the serum as compared to the control group. Immunohistochemically, irisin was significantly increased in immunoreactivity in the MTX group as compared to the control group (p < 0.05). Significant histopathological improvement and decrease in serum TOS levels were observed in the MTX + benfotiamine group compared to the MTX group (p 0.05).
Conclusions
Our results showed that MTX caused an increase in the activity of irisin after producing toxicity in the liver. In addition, we found that benfotiamine was effective in preventing damage caused by MTX in the liver. |
format |
article |
author |
Mehmet Ali Erdogan Alper Yalcin |
author_facet |
Mehmet Ali Erdogan Alper Yalcin |
author_sort |
Mehmet Ali Erdogan |
title |
Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats |
title_short |
Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats |
title_full |
Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats |
title_fullStr |
Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats |
title_full_unstemmed |
Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats |
title_sort |
protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats |
publisher |
Termedia Publishing House |
publishDate |
2019 |
url |
https://doaj.org/article/5da203d1c88d4527ad0775cdb99de6c9 |
work_keys_str_mv |
AT mehmetalierdogan protectiveeffectsofbenfotiamineonirisinactivityinmethotrexateinducedliverinjuryinrats AT alperyalcin protectiveeffectsofbenfotiamineonirisinactivityinmethotrexateinducedliverinjuryinrats |
_version_ |
1718377740688687104 |